Provision of Microgen Aspergillus (FSK) Antigens
Details
- Supplier(s)
- Microgen Bioproducts Ltd
- Value
- GBP 50,000
- Duration
- 2 years
- Topic
- Laboratory reagents
- Published
- 24 July 2019
- Source
- ContractsFinder
Tender description
Public Health England (PHE) awarded the contract for the provision of some Aspergillus Antigens consumables to Microgen Bioproducts. These range of products (FSK1CE), Avian (FSK4CE), M.faeni (FSK3CE) and Quickvue RSV kits are required for use in our Mycology Reference Laboratory.
Timeline
- Completed: Award date1 April 2019
- Completed: Award published24 July 2019Current notice
- Completed: Contract expiry date31 December 2020
About the buyer
Public Health England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33696500 · Laboratory reagents
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@public-health-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@public-health-england.gov |
6 similar open tenders
See more open tenders related to Provision of Microgen Aspergillus (FSK) Antigens.
- Open tender
MEDICAL TECHNOLOLGY (MEDTECH) INNOVATION DPS
- Open tender
Laboratory reagents
Related buyers
Buyers similar to Public Health England.
- 2,606£1.6bn
- 1,690£204.6bn
- 885£19.4bn
- 680£8.8bn
- 463£15.4bn
- 426£3.8bn
- 341£20.3m
- 295£367.1m
- 260£233.6m
- 258£901.0m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
